Status:
COMPLETED
Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation Therapy
Lead Sponsor:
University of Florida
Collaborating Sponsors:
Ocala Royal Dames
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a pilot study to determine if there are changes in heart function following completion of radiation therapy for breast cancer as measured by cardiac magnetic resonance imaging (cardiac MRI) sc...
Detailed Description
As part of this study, participants will have a cardiac MRI at baseline and a follow-up cardiac MRI within 1 year after completion of standard radiation therapy for left-sided breast cancer. The cardi...
Eligibility Criteria
Inclusion
- Left-sided breast cancer stage I-III.
- Indications for adjuvant regional nodal and breast or chest wall radiation therapy (RT).
- Women and men are allowed.
- Must be at least 18 years old at time of consent.
Exclusion
- Pregnant and/or breastfeeding women or patients of child-producing potential not willing to use contraception while on study.
- Prior history of cardiovascular disease per physician discretion.
- Stage 0 and IV breast cancer.
- Prior radiation therapy to chest.
- Concurrent trastuzumab per physician discretion.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT02199366
Start Date
September 1 2014
End Date
March 31 2025
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida Proton Therapy Institute
Jacksonville, Florida, United States, 32206